Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.02 BRL | +0.59% | +0.50% | -12.45% |
Mar. 04 | Barclays Downgrades Ambev to Equalweight From Overweight, Adjusts Price Target to $3 From $3.50 | MT |
Feb. 29 | Transcript : Ambev S.A., Q4 2023 Earnings Call, Feb 29, 2024 |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company returns high margins, thereby supporting business profitability.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company is one of the best yield companies with high dividend expectations.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Brewers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-12.45% | 36.63B | B- | ||
-4.04% | 119B | A- | ||
+384.45% | 67.41B | - | C- | |
+0.94% | 56.21B | B+ | ||
+8.26% | 47.88B | C+ | ||
+0.59% | 23.35B | - | B+ | |
+11.97% | 18.95B | B | ||
+3.96% | 17.64B | A- | ||
-25.17% | 18.05B | B | ||
+6.73% | 14.67B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ABEV3 Stock
- Ratings Ambev S.A.